HOOKIPA Pharma Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
HOOKIPA Pharma Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • HOOKIPA Pharma Inc. Return On Equity for the quarter ending September 30, 2024 was -49.3 %, a 29.8% increase year-over-year.
  • HOOKIPA Pharma Inc. annual Return On Equity for 2023 was -85.7 %, a 63.7% decline from 2022.
  • HOOKIPA Pharma Inc. annual Return On Equity for 2022 was -52.4 %, a 19.8% increase from 2021.
  • HOOKIPA Pharma Inc. annual Return On Equity for 2021 was -65.3 %, a 70.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -85.7 -33.4 -63.7% Jan 1, 2023 Dec 31, 2023
2022 -52.4 +12.9 +19.8% Jan 1, 2022 Dec 31, 2022
2021 -65.3 -27 -70.7% Jan 1, 2021 Dec 31, 2021
2020 -38.2 +17.4 +31.2% Jan 1, 2020 Dec 31, 2020
2019 -55.6 -85.4 -287% Jan 1, 2019 Dec 31, 2019
2018 29.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.